CD4+ T cell responses in human viral infection: lessons from hepatitis C.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
03 02 2020
Historique:
pubmed: 7 1 2020
medline: 5 9 2020
entrez: 7 1 2020
Statut: ppublish

Résumé

Liver disease as a result of chronic hepatitis C virus (HCV) infection is a global problem. While some HCV infections resolve spontaneously, viral persistence associates with compromised T cell immunity. In this issue of the JCI, Chen et al. and Coss et al. explored virus-specific CD4+ T cell response during HCV infection. Both studies evaluated the HCV-specific T cells of patients with different courses of infection. Chen et al. revealed that initial CD4+ T cell responses are similar during early infection and that T cell failure resulted from loss of the virus-specific T cells themselves. Coss et al. showed that HCV-specific CD4+ T cells temporarily recovered in some women following childbirth. These studies contribute to our understanding of CD4+ T cell functionality during different natural courses of infection, with the notable implication that restoring CD4+ T cell immunity might contribute to controlling HCV infection.

Identifiants

pubmed: 31904589
pii: 133222
doi: 10.1172/JCI133222
pmc: PMC6994135
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-597

Commentaires et corrections

Type : CommentOn
Type : CommentOn

Références

Nat Commun. 2017 May 03;8:15050
pubmed: 28466857
J Hepatol. 2018 Nov;69(5):1007-1014
pubmed: 30142429
Nat Med. 2013 Nov;19(11):1529-33
pubmed: 24162814
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10684-9
pubmed: 27601657
J Hepatol. 2017 May;66(5):888-896
pubmed: 28040549
J Immunol. 2005 Sep 15;175(6):3603-13
pubmed: 16148104
Science. 2003 Oct 24;302(5645):659-62
pubmed: 14576438
J Exp Med. 2012 Jan 16;209(1):61-75
pubmed: 22213804
Gastroenterology. 2016 Mar;150(3):696-706.e3
pubmed: 26584604
PLoS One. 2007 Jul 25;2(7):e649
pubmed: 17653276
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8
pubmed: 12441397
Gastroenterology. 2019 Jan;156(2):369-383
pubmed: 30267712
J Clin Invest. 2020 Feb 3;130(2):748-753
pubmed: 31904583
Sci Rep. 2019 Jul 23;9(1):10624
pubmed: 31337800
J Clin Invest. 2020 Feb 3;130(2):768-773
pubmed: 31904582
Hepatology. 1995 Mar;21(3):632-8
pubmed: 7875660
Hepatology. 2003 May;37(5):1189-98
pubmed: 12717401
Hepatology. 2001 Jan;33(1):267-76
pubmed: 11124845
Gastroenterology. 2011 Oct;141(4):1422-31, 1431.e1-6
pubmed: 21763239
J Exp Med. 2001 Nov 19;194(10):1395-406
pubmed: 11714747
Lancet. 1995 Oct 14;346(8981):1006-7
pubmed: 7475549
J Viral Hepat. 2016 Dec;23(12):985-993
pubmed: 27558465
PLoS Pathog. 2010 Jun 10;6(6):e1000947
pubmed: 20548953
J Clin Invest. 1996 Aug 1;98(3):706-14
pubmed: 8698862

Auteurs

Benedikt Binder (B)

Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
IMM-PACT Clinician Scientist Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Robert Thimme (R)

Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH